AAM Succeeds As California Court Temporarily Blocks Pay-For-Delay Law
Court ‘Cannot Reasonably Find’ That Bill Regulates California Commerce Alone
A judge in California has agreed to instate a temporary injunction against a state law designed to curb so-called ‘pay-for-delay’ deals, handing victory to generics and biosimilars industry association the AAM.
You may also be interested in...
Proposed state legislation restricting patent settlements set out in Oregon’s SB 764 bill is “unnecessary,” the AAM has insisted, opposing the “unconstitutional” legislation by citing delayed patient access to affordable medicines, the obstruction of expedited patent settlements and benefits to brand-name pharmaceutical companies which will eventually lead to price rises.
‘We need the pharmaceutical industry … to always feel we’ve got their back to innovate,’ Becerra tells Senate Committee. ‘But we have to ensure that we’re getting our dollars’ worth.’
A court timeline has been set out for the latest attack by the AAM on Californian legislation that deems “pay-for-delay” litigation settlement deals anticompetitive.